Effect of phiC31 integrase-mediated low density lipoprotein receptor gene therapy on atherosclerosis in mice
CSTR:
Author:
Affiliation:

Department of Biochemistry and Molecular Biology, Guizhou Medical University, Guiyang, Guizhou 550025, China)

Clc Number:

R363

  • Article
  • | |
  • Metrics
  • |
  • Reference [14]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    Aim PhiC31 integrase directs foreign DNA containing with attB integration into specific genomic DNA, incurring long-term and stable expression. This study analyzed the effect of LDLR expression mediated by phiC31 integrase on lipoprotein profile and atherosclerosis in family hypercholesterolaemia mice (LDLR-/-). Methods Male LDLR-/- mice were tail vein co-injected with phiC31 integrase expression plasmid pCMV-int and plasmid pcDNA 3.1-TBG-LDLR-attB carried with LDLR gene and attB sequence. Mice co-injected with pCMV-int and pcDNA3.1-TBG-LDLR lacking attB sequence were used as control. Results LDLR directed by thyroxine binding globulin promoter and mediated by phiC31 integrase maintained higher and persistent expression in H22 cells and specifically in livers from mice injected with pcDNA3.1-TBG-LDLR-attB. The expression reduced serum low density lipoprotein cholesterol (LDLC) levels up to 35%, and resulted in decreases by 19% of plaque size/lumen area in cross section at ascending aorta compared with mice co-injected with pCMV-int and pcDNA3.1-TBG-LDLR. Conclusion The expression of LDLR mediated by phiC31 integrase improved lipoprotein profile and ameliorated atherosclerosis in LDLR-/- mice.

    Reference
    [1] 王绿娅, 许瑛杰, 陈保生.家族性高胆固醇血症样表型的临床特点及基因诊断.中国动脉硬化杂志, 8,6 (1):69-71.
    [2] 陈保生, 李德岭, 任渝棠.越低越好,越快越好?——他汀类药物强化降脂利弊谈.中国动脉硬化杂志, 6,4 (9):737-740.
    [3] 马晴雯.φC31整合酶系统介导的位点特异性整合研究进展.遗传, 1,3(6):567-575.
    [4] Otani Y, Kawakami S, Mukai H, et al.Long-term in vivo gene expression in mouse kidney using φC31 integrase and electroporation .J Drug Target, 5,3(5):427-435.
    [5] Ortiz-Urda S, Thyagarajan B, Keene DR, et al.Stable nonviral genetic correction of inherited human skin disease .Nat Med, 2,8(10):1 166-170.
    [6] Chen Z, Chu D, Castro-Perez JM, et al.AAV8-mediated long-term expression of human LCAT significantly improves lipid profiles in hCETP; Ldlr(+/-) mice.J Cardiovasc Transl Res, 1,4(6):801-810.
    [7] Belalcazar LM, Merched A, Carr B, et al.Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.Circulation, 3,7(21):2 726-732.
    [8] Li G, Biju KC, Xu X, et al.Macrophage LXRα gene therapy ameliorates atherosclerosis as well as hypertriglyceridemia in LDLR(-/-) mice .Gene Ther, 1,8(8):835-841.
    [9] Hibbitt O, Agkatsev S, Owen C, et al.RNAi-mediated knockdown of HMGCoA reductase enhances gene expression from physiologically regulated low-density lipoprotein receptor therapeutic vectors in vivo .Gene Ther, 2,9(4):463-467.
    [10] Hibbitt OC, McNeil E, Lufino MM, et al.Long-term physiologically regulated expression of the low-density lipoprotein receptor in vivo using genomic DNA mini-gene constructs .Mol Ther, 0,8 (2):317-326.
    [11] Craeyveld EV, Gordts SC, Nefyodova E, et al.Regression and stabilization of advanced murine atherosclerotic lesions:a comparison of LDL lowering and HDL raising gene transfer strategies .J Mol Med, 1,9 (6):555-567.
    [12] Chen SJ, Sanmiguel J, Lock M, et al.Biodistribution of AAV8 vectors expressing human low-density lipoprotein receptor in a mouse model of homozygous familial hypercholesterolemia .Hum Gene Ther Clin Dev, 3,4 (4):154-160.
    [13] Kassim SH, Li H, Vandenberghe LH, et al.Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis .PLoS One, 0,5 (10):e13 424.
    [14] Kaeppel C, Beattie SG, Fronza R, et al.A largely random AAV integration profile after LPLD gene therapy .Nat Med, 3,9 (7):889-891.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

DENG Yan, XU Xiao-Ting, LEI Ting-Wen, OU Hai-Long. Effect of phiC31 integrase-mediated low density lipoprotein receptor gene therapy on atherosclerosis in mice[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2018,26(6):572-576.

Copy
Share
Article Metrics
  • Abstract:983
  • PDF: 815
  • HTML: 0
  • Cited by: 0
History
  • Received:January 04,2018
  • Revised:February 05,2018
  • Online: July 10,2018
Article QR Code